Pharma Journalist 8947 posts 0 comments

Amgen and Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI (trastuzumab-anns) for all approved indications of the reference product,…
Read More...

Camargo Pharmaceutical Services announced that it will acquire InSymbiosis, a Canadian drug development partner which improves how biopharma companies outsource R&D. This…
Read More...

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or…
Read More...

Terns Pharmaceuticals announced the initiation of a Phase 1 clinical trial of TERN-101, a farnesoid X receptor (FXR) agonist, being developed for the treatment of non-alcoholic…
Read More...

SMi Reports: Updated brochure released with the full two-day agenda for the inaugural Pharmaceutical Cleanroom Technology conference this October in London, UK Since the release of the…
Read More...

Pfizer Inc. announced positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to severely active rheumatoid arthritis (RA). Patients who achieved low…
Read More...

Debiopharm and Ipsen announced renewal of their Decapeptyl agreement, which extends and strengthens their strategic partnership through 2034 for the development, manufacturing and…
Read More...

Novartis announced new data from the MAXIMISE trial evaluating the efficacy and safety of Cosentyx (secukinumab) in the management of axial manifestations of psoriatic arthritis (PsA).…
Read More...

Harbour BioMed (HBM) and Erasmus MC, University Medical Center Rotterdam announced that they have signed a 10-year Memorandum of Understanding (MOU) to enable a broad range of joint…
Read More...

Swedish Orphan Biovitrum AB (publ) (Sobi) has signed an agreement to acquire, from Novimmune’s shareholders, a newly established company owning emapalumab and related assets, giving…
Read More...